GAD2 and paraneoplastic neurologic syndrome: By contrast, due to the fact that IgLON5 and GAD65 are currently not considered PNS associated antibodies, these two cases were classified as non-PNS according to the 2021 PNS-Care criteria (Table 1) [5].